Live from the NIH registry
Studies recruiting near Columbus right now
Top 25 of 71 recruiting studies, sorted by proximity — each links to its official registry page
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Lane Dermatology and Dermatologic Surgery — Columbus, Georgia (7.3 mi)
· Sponsor: Incyte Corporation
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
IACT Health-Brookstone Centre Pkwy — Columbus, Georgia (7.3 mi)
· Sponsor: Sparrow Pharmaceuticals
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Centricity Research, Endocrine Consultants — Columbus, Georgia (7.3 mi)
· Sponsor: Boehringer Ingelheim
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Regeneron Pharmaceuticals
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: vTv Therapeutics
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 500 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bristol-Myers Squibb
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
Triple Negative Breast Cancer
Phase 3
Interventional 657 participants sought
Columbus Regional Research Institute, LLC — Columbus, Georgia (7.3 mi)
· Sponsor: Jina Pharmaceuticals Inc.
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: University of Rochester
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer, Sarcopenia
N/A
Observational 300 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Columbus, Georgia (7.3 mi)
· Sponsor: Alnylam Pharmaceuticals
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Atopic Dermatitis
Phase 3
Interventional 200 participants sought
Centricity Research Columbus Dermatology /ID# 266529 — Columbus, Georgia (7.3 mi)
· Sponsor: AbbVie
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Alzheimer's Research and Treatment Center - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Hoffmann-La Roche
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Phase 3
Interventional 780 participants sought
Centricity Research Columbus Cancer Center ( Site 0005) — Columbus, Georgia (7.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Pericarditis, Pericarditis Acute
Phase 2, Phase 3
Interventional 325 participants sought
Investigational Site 001 — Columbus, Georgia (7.3 mi)
· Sponsor: Kiniksa Pharmaceuticals International, plc
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
DaVita Clinical Research Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
An Internet-based Program to Help Cancer Survivors Manage Pain
Cancer
N/A
Interventional 456 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
DCR Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Takeda
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Phase 3
Interventional 444 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bayer
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Phase 2
Interventional 300 participants sought
Columbus Memory Center — Columbus, Georgia (7.3 mi)
· Sponsor: Lighthouse Pharmaceuticals, Inc.
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion
N/A
Interventional 126 participants sought
Hughston Foundation Inc — Columbus, Georgia (7.3 mi)
· Sponsor: Kuros Biosurgery AG
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 3
Interventional 80 participants sought
Columbus Research Foundation — Columbus, Georgia (7.3 mi)
· Sponsor: Novo Nordisk A/S